{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T17:34:48Z","timestamp":1770744888893,"version":"3.49.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T00:00:00Z","timestamp":1770508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173173"],"award-info":[{"award-number":["82173173"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-026-02068-9","type":"journal-article","created":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T10:32:57Z","timestamp":1770546777000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["PRKD1\/EIF5A\/\u03b2-catenin axis inhibits tumorigenesis and metastasis in non-small-cell lung cancer"],"prefix":"10.1007","volume":"26","author":[{"given":"Yu","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijun","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiajia","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Huo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiqing","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,8]]},"reference":[{"key":"2068_CR1","doi-asserted-by":"crossref","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. (2025) Cancer statistics, 2025 CA: a cancer journal for clinicians 75(1):10\u201345.","DOI":"10.3322\/caac.21871"},{"issue":"5","key":"2068_CR2","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/S0025-6196(11)60735-0","volume":"83","author":"JR Molina","year":"2008","unstructured":"Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc. 2008;83(5):584\u201394. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18452692.","journal-title":"Mayo Clin Proc"},{"key":"2068_CR3","doi-asserted-by":"publisher","first-page":"110775","DOI":"10.1016\/j.biopha.2020.110775","volume":"131","author":"R Ye","year":"2020","unstructured":"Ye R, Tang R, Gan S, Li R, Cheng Y, Guo L, et al. New insights into long non-coding RNAs in non-small cell lung cancer. Biomed Pharmacother. 2020;131:110775. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/33152934.","journal-title":"Biomed Pharmacother"},{"issue":"11","key":"2068_CR4","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1016\/j.annonc.2020.07.014","volume":"31","author":"F Mosele","year":"2020","unstructured":"Mosele F, Remon J, Mateo J, Westphalen CB, Barlesi F, Lolkema MP, et al. Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO precision medicine working group. Ann Oncol. 2020;31(11):1491\u2013505. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32853681.","journal-title":"Ann Oncol"},{"issue":"1","key":"2068_CR5","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1038\/s41467-021-22971-x","volume":"12","author":"L Liu","year":"2021","unstructured":"Liu L, Tao T, Liu S, Yang X, Chen X, Liang J, et al. An RFC4\/Notch1 signaling feedback loop promotes NSCLC metastasis and stemness. Nat Commun. 2021;12(1):2693. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/33976158.","journal-title":"Nat Commun"},{"key":"2068_CR6","doi-asserted-by":"crossref","unstructured":"Bhattacharjee A, Richards WG, Staunton J, Li C, Monti S, Vasa P et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. 2001; Proc Natl Acad Sci U S A, 98(24):13790\u20135. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11707567","DOI":"10.1073\/pnas.191502998"},{"key":"2068_CR7","doi-asserted-by":"publisher","first-page":"102178","DOI":"10.1016\/j.ctrv.2021.102178","volume":"95","author":"J Remon","year":"2021","unstructured":"Remon J, Pignataro D, Novello S, Passiglia F. Current treatment and future challenges in ROS1- and ALK-rearranged advanced non-small cell lung cancer. Cancer Treat Rev. 2021;95:102178. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/33743408.","journal-title":"Cancer Treat Rev"},{"issue":"18","key":"2068_CR8","doi-asserted-by":"publisher","first-page":"8572","DOI":"10.1073\/pnas.91.18.8572","volume":"91","author":"AM Valverde","year":"1994","unstructured":"Valverde AM, Sinnett-Smith J, Van Lint J, Rozengurt E. Molecular cloning and characterization of protein kinase D: a target for Diacylglycerol and phorbol esters with a distinctive catalytic domain. Proc Natl Acad Sci U S A. 1994;91(18):8572\u20136. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8078925.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"2068_CR9","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1124\/molpharm.121.000341","volume":"100","author":"SF Steinberg","year":"2021","unstructured":"Steinberg SF. Decoding the cardiac actions of protein kinase D isoforms. Mol Pharmacol. 2021;100(6):558\u201367. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/34531296.","journal-title":"Mol Pharmacol"},{"issue":"2","key":"2068_CR10","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1161\/CIRCRESAHA.107.168211","volume":"102","author":"M Avkiran","year":"2008","unstructured":"Avkiran M, Rowland AJ, Cuello F, Haworth RS. Protein kinase d in the cardiovascular system: emerging roles in health and disease. Circ Res. 2008;102(2):157\u201363. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18239146.","journal-title":"Circ Res"},{"key":"2068_CR11","doi-asserted-by":"crossref","unstructured":"Massadeh S, Albeladi M, Albesher N, Alhabshan F, Kampe KD, Chaikhouni F et al. 2021;12(5):612.Novel autosomal recessive Splice-Altering variant in PRKD1 is associated with congenital heart disease. Genes (Basel) 12(5). https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/33919081","DOI":"10.3390\/genes12050612"},{"issue":"9","key":"2068_CR12","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/ng.3627","volume":"48","author":"A Sifrim","year":"2016","unstructured":"Sifrim A, Hitz MP, Wilsdon A, Breckpot J, Turki SH, Thienpont B, et al. Distinct genetic architectures for syndromic and nonsyndromic congenital heart defects identified by exome sequencing. Nat Genet. 2016;48(9):1060\u20135. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27479907.","journal-title":"Nat Genet"},{"issue":"4","key":"2068_CR13","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/jdi.13714","volume":"13","author":"C Pan","year":"2022","unstructured":"Pan C, Li M, Wang J, Chu X, Xiong J, Yang X, et al. miR-4431 targets TRIP10\/PRKD1 and impairs glucose metabolism. J Diabetes Investig. 2022;13(4):617\u201327. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/34800086.","journal-title":"J Diabetes Investig"},{"issue":"2","key":"2068_CR14","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.cell.2008.11.018","volume":"136","author":"G Sumara","year":"2009","unstructured":"Sumara G, Formentini I, Collins S, Sumara I, Windak R, Bodenmiller B, et al. Regulation of PKD by the MAPK p38delta in insulin secretion and glucose homeostasis. Cell. 2009;136(2):235\u201348. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19135240.","journal-title":"Cell"},{"issue":"49","key":"2068_CR15","doi-asserted-by":"publisher","first-page":"21181","DOI":"10.1073\/pnas.1011651107","volume":"107","author":"KC Kong","year":"2010","unstructured":"Kong KC, Butcher AJ, McWilliams P, Jones D, Wess J, Hamdan FF, et al. M3-muscarinic receptor promotes insulin release via receptor phosphorylation\/arrestin-dependent activation of protein kinase D1. Proc Natl Acad Sci U S A. 2010;107(49):21181\u20136. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21078968.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"2068_CR16","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1111\/jcmm.12322","volume":"18","author":"M Karam","year":"2014","unstructured":"Karam M, Bieche I, Legay C, Vacher S, Auclair C, Ricort JM. Protein kinase D1 regulates ERalpha-positive breast cancer cell growth response to 17beta-estradiol and contributes to poor prognosis in patients. J Cell Mol Med. 2014;18(12):2536\u201352. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25287328.","journal-title":"J Cell Mol Med"},{"issue":"11","key":"2068_CR17","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1158\/2159-8290.CD-RW2014-208","volume":"4","author":"PRKD1","year":"2014","unstructured":"Weinreb I, Piscuoglio S, Martelotto LG, Waggott D, Ng CK, Perez-Ordonez B et al: Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands. 2014 Nature genetics, 46(11):1166-1169.\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/25240283.","journal-title":"Cancer Discov"},{"key":"2068_CR18","doi-asserted-by":"publisher","first-page":"8235121","DOI":"10.1155\/2016\/8235121","volume":"2016","author":"DK Sharma","year":"2016","unstructured":"Sharma DK, Bressler K, Patel H, Balasingam N, Thakor N. Role of eukaryotic initiation factors during cellular stress and cancer progression. J Nucleic Acids. 2016;2016:8235121. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28083147.","journal-title":"J Nucleic Acids"},{"issue":"5","key":"2068_CR19","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1002\/j.1460-2075.1994.tb06370.x","volume":"13","author":"A Pause","year":"1994","unstructured":"Pause A, Methot N, Svitkin Y, Merrick WC, Sonenberg N. Dominant negative mutants of mammalian translation initiation factor eIF-4A define a critical role for eIF-4F in cap-dependent and cap-independent initiation of translation. EMBO J. 1994;13(5):1205\u201315. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8131750.","journal-title":"EMBO J"},{"issue":"1","key":"2068_CR20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.canlet.2013.06.019","volume":"340","author":"R Spilka","year":"2013","unstructured":"Spilka R, Ernst C, Mehta AK, Haybaeck J. Eukaryotic translation initiation factors in cancer development and progression. Cancer Lett. 2013;340(1):9\u201321. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23830805.","journal-title":"Cancer Lett"},{"issue":"45","key":"2068_CR21","doi-asserted-by":"publisher","first-page":"27827","DOI":"10.1016\/S0021-9258(18)46861-5","volume":"269","author":"MH Park","year":"1994","unstructured":"Park MH, Wolff EC, Lee YB, Folk JE. Antiproliferative effects of inhibitors of Deoxyhypusine synthase. Inhibition of growth of Chinese hamster ovary cells by guanyl diamines. J Biol Chem. 1994;269(45):27827\u201332. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7961711.","journal-title":"J Biol Chem"},{"issue":"12","key":"2068_CR22","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/0968-0004(93)90010-K","volume":"18","author":"MH Park","year":"1993","unstructured":"Park MH, Wolff EC, Folk JE. Is hypusine essential for eukaryotic cell proliferation? Trends Biochem Sci. 1993;18(12):475\u20139. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8108861.","journal-title":"Trends Biochem Sci"},{"issue":"10","key":"2068_CR23","doi-asserted-by":"publisher","first-page":"2914","DOI":"10.1093\/emboj\/17.10.2914","volume":"17","author":"D Zuk","year":"1998","unstructured":"Zuk D, Jacobson A. A single amino acid substitution in yeast eIF-5A results in mRNA stabilization. EMBO J. 1998;17(10):2914\u201325. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9582285.","journal-title":"EMBO J"},{"issue":"4","key":"2068_CR24","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.tplants.2004.02.008","volume":"9","author":"JE Thompson","year":"2004","unstructured":"Thompson JE, Hopkins MT, Taylor C, Wang TW. Regulation of senescence by eukaryotic translation initiation factor 5A: implications for plant growth and development. Trends Plant Sci. 2004;9(4):174\u20139. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15063867.","journal-title":"Trends Plant Sci"},{"issue":"16","key":"2068_CR25","doi-asserted-by":"publisher","first-page":"4774","DOI":"10.7150\/jca.58168","volume":"12","author":"L Li","year":"2021","unstructured":"Li L, Li X, Zhang Q, Ye T, Zou S, Yan J. EIF5A expression and its role as a potential diagnostic biomarker in hepatocellular carcinoma. J Cancer. 2021;12(16):4774\u20139. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/34234848.","journal-title":"J Cancer"},{"issue":"4","key":"2068_CR26","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.1111\/jcmm.14167","volume":"23","author":"Z Wang","year":"2019","unstructured":"Wang Z, Jiang J, Qin T, Xiao Y, Han L. EIF5A regulates proliferation and chemoresistance in pancreatic cancer through the sHH signalling pathway. J Cell Mol Med. 2019;23(4):2678\u201388. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30761741.","journal-title":"J Cell Mol Med"},{"issue":"12","key":"2068_CR27","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1038\/emboj.2012.150","volume":"31","author":"T Valenta","year":"2012","unstructured":"Valenta T, Hausmann G, Basler K. The many faces and functions of \u03b2-catenin. EMBO J. 2012;31(12):2714\u201336.","journal-title":"EMBO J"},{"issue":"6","key":"2068_CR28","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","volume":"169","author":"R Nusse","year":"2017","unstructured":"Nusse R, Clevers H. Wnt\/\u03b2-Catenin Signaling, Disease, and emerging therapeutic modalities. Cell. 2017;169(6):985\u201399.","journal-title":"Cell"},{"issue":"1","key":"2068_CR29","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1038\/s41467-019-09289-5","volume":"10","author":"F Yang","year":"2019","unstructured":"Yang F, Xu J, Li H, Tan M, Xiong X, Sun Y. FBXW2 suppresses migration and invasion of lung cancer cells via promoting \u03b2-catenin ubiquitylation and degradation. Nat Commun. 2019;10(1):1382.","journal-title":"Nat Commun"},{"issue":"1","key":"2068_CR30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrc3419","volume":"13","author":"JN Anastas","year":"2013","unstructured":"Anastas JN, Moon RT. WNT signalling pathways as therapeutic targets in cancer. Nat Rev Cancer. 2013;13(1):11\u201326.","journal-title":"Nat Rev Cancer"},{"key":"2068_CR31","doi-asserted-by":"publisher","first-page":"33758","DOI":"10.1038\/srep33758","volume":"6","author":"H D\u00f6ppler","year":"2016","unstructured":"D\u00f6ppler H, Panayiotou R, Reid EM, Maimo W, Bastea L, Storz P. The PRKD1 promoter is a target of the KRas-NF-\u03baB pathway in pancreatic cancer. Sci Rep. 2016;6:33758.","journal-title":"Sci Rep"},{"issue":"2","key":"2068_CR32","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/S0006-291X(03)01161-6","volume":"307","author":"M Jaggi","year":"2003","unstructured":"Jaggi M, Rao PS, Smith DJ, Hemstreet GP, Balaji KC. Protein kinase C mu is down-regulated in androgen-independent prostate cancer. Biochem Biophys Res Commun. 2003;307(2):254\u201360. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12859948.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"2068_CR33","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1158\/0008-5472.CAN-07-6270","volume":"69","author":"C Du","year":"2009","unstructured":"Du C, Jaggi M, Zhang C, Balaji KC. Protein kinase D1-mediated phosphorylation and subcellular localization of beta-catenin. Cancer Res. 2009;69(3):1117\u201324. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19141652.","journal-title":"Cancer Res"},{"issue":"1","key":"2068_CR34","doi-asserted-by":"publisher","first-page":"R13","DOI":"10.1186\/bcr2232","volume":"11","author":"T Eiseler","year":"2009","unstructured":"Eiseler T, Doppler H, Yan IK, Goodison S, Storz P. Protein kinase D1 regulates matrix metalloproteinase expression and inhibits breast cancer cell invasion. Breast Cancer Res. 2009;11(1):R13. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19243594.","journal-title":"Breast Cancer Res"},{"issue":"3","key":"2068_CR35","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1093\/carcin\/bgm291","volume":"29","author":"M Kim","year":"2008","unstructured":"Kim M, Jang HR, Kim JH, Noh SM, Song KS, Cho JS, et al. Epigenetic inactivation of protein kinase D1 in gastric cancer and its role in gastric cancer cell migration and invasion. Carcinogenesis. 2008;29(3):629\u201337. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18283041.","journal-title":"Carcinogenesis"},{"issue":"2","key":"2068_CR36","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1158\/0008-5472.CAN-18-3241","volume":"80","author":"D Georgess","year":"2020","unstructured":"Georgess D, Padmanaban V, Sirka OK, Coutinho K, Choi A, Frid G, et al. Twist1-Induced epithelial dissemination requires Prkd1 signaling. Cancer Res. 2020;80(2):204\u201318. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31676574.","journal-title":"Cancer Res"},{"key":"2068_CR37","doi-asserted-by":"publisher","first-page":"33758","DOI":"10.1038\/srep33758","volume":"6","author":"H Doppler","year":"2016","unstructured":"Doppler H, Panayiotou R, Reid EM, Maimo W, Bastea L, Storz P. The PRKD1 promoter is a target of the KRas-NF-kappaB pathway in pancreatic cancer. Sci Rep. 2016;6:33758. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27649783.","journal-title":"Sci Rep"},{"issue":"6","key":"2068_CR38","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","volume":"149","author":"H Clevers","year":"2012","unstructured":"Clevers H, Nusse R. Wnt\/beta-catenin signaling and disease. Cell. 2012;149(6):1192\u2013205. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22682243.","journal-title":"Cell"},{"key":"2068_CR39","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.critrevonc.2015.12.005","volume":"99","author":"Y Duchartre","year":"2016","unstructured":"Duchartre Y, Kim YM, Kahn M. The Wnt signaling pathway in cancer. Crit Rev Oncol Hematol. 2016;99:141\u20139. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26775730.","journal-title":"Crit Rev Oncol Hematol"},{"key":"2068_CR40","doi-asserted-by":"crossref","unstructured":"Polakis P. 2012; 4(5):a008052. Wnt signaling in cancer. Cold Spring Harb Perspect Biol 4(5). https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22438566","DOI":"10.1101\/cshperspect.a008052"},{"key":"2068_CR41","doi-asserted-by":"publisher","first-page":"104794","DOI":"10.1016\/j.phrs.2020.104794","volume":"160","author":"X Zhang","year":"2020","unstructured":"Zhang X, Wang L, Qu Y. Targeting the beta-catenin signaling for cancer therapy. Pharmacol Res. 2020;160:104794. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32278038.","journal-title":"Pharmacol Res"},{"issue":"1","key":"2068_CR42","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13045-019-0711-z","volume":"12","author":"CY Wei","year":"2019","unstructured":"Wei CY, Zhu MX, Yang YW, Zhang PF, Yang X, Peng R, et al. Downregulation of RNF128 activates Wnt\/beta-catenin signaling to induce cellular EMT and stemness via CD44 and CTTN ubiquitination in melanoma. J Hematol Oncol. 2019;12(1):21. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30832692.","journal-title":"J Hematol Oncol"},{"issue":"5","key":"2068_CR43","first-page":"2141","volume":"25","author":"K Manios","year":"2020","unstructured":"Manios K, Tsiambas E, Stavrakis I, Stamatelopoulos A, Kavantzas N, Agrogiannis G, et al. c-Fos\/ c-Jun transcription factors in non-small cell lung carcinoma. J BUON. 2020;25(5):2141\u20133. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/33277827.","journal-title":"J BUON"},{"issue":"2","key":"2068_CR44","doi-asserted-by":"publisher","first-page":"609","DOI":"10.21873\/anticanres.13990","volume":"40","author":"P Chanvorachote","year":"2020","unstructured":"Chanvorachote P, Sriratanasak N, Nonpanya N. C-myc contributes to malignancy of lung cancer: A potential anticancer drug target. Anticancer Res. 2020;40(2):609\u201318. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32014901.","journal-title":"Anticancer Res"},{"issue":"2","key":"2068_CR45","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1080\/14728222.2020.1723548","volume":"24","author":"D Masso-Valles","year":"2020","unstructured":"Masso-Valles D, Beaulieu ME, Soucek L. MYC, MYCL, and MYCN as therapeutic targets in lung cancer. Expert Opin Ther Targets. 2020;24(2):101\u201314. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32003251.","journal-title":"Expert Opin Ther Targets"},{"issue":"18","key":"2068_CR46","doi-asserted-by":"publisher","first-page":"5551","DOI":"10.1016\/S0021-9258(17)33095-8","volume":"251","author":"WM Kemper","year":"1976","unstructured":"Kemper WM, Berry KW, Merrick WC. Purification and properties of rabbit reticulocyte protein synthesis initiation factors M2Balpha and M2Bbeta. J Biol Chem. 1976;251(18):5551\u20137. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/965377.","journal-title":"J Biol Chem"},{"issue":"3","key":"2068_CR47","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1002\/jcb.20658","volume":"97","author":"DL Jao","year":"2006","unstructured":"Jao DL, Chen KY. Tandem affinity purification revealed the hypusine-dependent binding of eukaryotic initiation factor 5A to the translating 80S ribosomal complex. J Cell Biochem. 2006;97(3):583\u201398. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16215987.","journal-title":"J Cell Biochem"},{"issue":"4","key":"2068_CR48","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/j.bbrc.2006.07.195","volume":"348","author":"CF Zanelli","year":"2006","unstructured":"Zanelli CF, Maragno AL, Gregio AP, Komili S, Pandolfi JR, Mestriner CA, et al. eIF5A binds to translational machinery components and affects translation in yeast. Biochem Biophys Res Commun. 2006;348(4):1358\u201366. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16914118.","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-026-02068-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02068-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02068-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T03:03:40Z","timestamp":1770692620000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-026-02068-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,8]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2068"],"URL":"https:\/\/doi.org\/10.1007\/s10238-026-02068-9","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,8]]},"assertion":[{"value":"27 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent for participate"}}],"article-number":"134"}}